IRCT138711201155N4
Completed
Phase 3
Comparison of Pegylated Interferon alfa-2a plus Adefovir and Pegylated Interferon alfa-2a alone in the treatment of chronic hepatitis B with genotype D (multicenter study)
Guilan University of Medical Sciences0 sites74 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Chronic hepatitis B.
- Sponsor
- Guilan University of Medical Sciences
- Enrollment
- 74
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Presence of hepatitis B for more than 6 month, ALT more than 1/1 normal upper limit and less than 10 ULN, 1810\.000 copies/ml.
- •Exclusion criteria: Receiving anti neoplasm, anti viral or immunomedulator drugs during 6 months prior to study, previous treatment, coinfection with Hepatitis A,C,D viruses or HIV, Severe dysfunction of liver and kidney, pregnancy, breast feeding, refusing to give informed consent .
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 3
A study of peginterferon alfa-2a in combination with ribavirin in patients with chronic Hepatitis C.Chronic hepatitis CJPRN-jRCT2080220023Chugai Pharmaceutical Co., Ltd.
Unknown
Phase 2
A study of peginterferon alfa-2a in combination with ribavirin in chronic hepatitis C(CHC) patients with compensated liver cirrhosis(LC).CHC with compensated LCJPRN-jRCT2080220215Chugai Pharmaceutical Co., Ltd.
Recruiting
Phase 3
Comparison of the effect of interferon alfa 2 b (IFN-a2b) drops with mitomycin c during surgery on pterygium recurrence in pterygium surgeryPterygium.Pterygium of eyeH11.0IRCT20160919029871N5Rasht University of Medical Sciences58
Completed
Not Applicable
The effectiveness of peginterferon -alpha2a and the entecavir combination therapy for the chronic hepatitis B patientJPRN-UMIN000016275Kinki University School of Medicine50
Completed
Not Applicable
A dose comparing study of peginterferon alfa-2b plus ribavirin in chronic hepatitis type C except genotype 1 and high pretreatment viremia.: A randomized open-label pilot study.JPRN-C000000313Hiroshima liver study group120